Abstract
BackgroundGenetic markers for thyroid cancers identified by microarray analysis have offered limited predictive accuracy so far because of the few classes of thyroid lesions usually taken into account. To improve diagnostic relevance, we have simultaneously analyzed microarray data from six public datasets covering a total of 347 thyroid tissue samples representing 12 histological classes of follicular lesions and normal thyroid tissue. Our own dataset, containing about half the thyroid tissue samples, included all categories of thyroid lesions.Methodology/Principal FindingsClassifier predictions were strongly affected by similarities between classes and by the number of classes in the training sets. In each dataset, sample prediction was improved by separating the samples into three groups according to class similarities. The cross-validation of differential genes revealed four clusters with functional enrichments. The analysis of six of these genes (APOD, APOE, CLGN, CRABP1, SDHA and TIMP1) in 49 new samples showed consistent gene and protein profiles with the class similarities observed. Focusing on four subclasses of follicular tumor, we explored the diagnostic potential of 12 selected markers (CASP10, CDH16, CLGN, CRABP1, HMGB2, ALPL2, ADAMTS2, CABIN1, ALDH1A3, USP13, NR2F2, KRTHB5) by real-time quantitative RT-PCR on 32 other new samples. The gene expression profiles of follicular tumors were examined with reference to the mutational status of the Pax8-PPARγ, TSHR, GNAS and NRAS genes.Conclusion/SignificanceWe show that diagnostic tools defined on the basis of microarray data are more relevant when a large number of samples and tissue classes are used. Taking into account the relationships between the thyroid tumor pathologies, together with the main biological functions and pathways involved, improved the diagnostic accuracy of the samples. Our approach was particularly relevant for the classification of microfollicular adenomas.
Highlights
Over the past few years, the use of microarray technologies has contributed to the identification of new markers for the diagnosis and prognosis of human tumors
Molecular classification of thyroid pathologies To analyze the global classification of the follicular thyroid lesions in the Fontaine dataset, we defined the centroid of each class of tissue by a composite signature of mean gene-expression levels
None of these markers has proved satisfactory in clinical practice, possibly because only a small number of thyroid tumor classes were initially taken into account
Summary
Over the past few years, the use of microarray technologies has contributed to the identification of new markers for the diagnosis and prognosis of human tumors. Microarray analyses of thyroid tumors have essentially compared two classes of tissue [6,7,8,9,10,11] These studies have either searched for specific markers by comparing a particular class of thyroid tumor to the corresponding normal tissue, or looked for markers of malignancy by examining the most frequent benign and malignant classes of thyroid tumor (usually the FTA and PTC classes). The CITED1 gene, which was claimed to be a significant marker distinguishing PTC from normal tissue [9] turned out to be less specific when data from FTC samples were included [8]. Our own dataset, containing about half the thyroid tissue samples, included all categories of thyroid lesions
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.